Fundraising Fox

Ngm Biopharmaceuticals

South San Francisco, US · Delaware corporation · 3 known investors

Founders & leadership

JC
Jin-Long ChenFounder
WJ
William J. RieflinExecutive
DV
David V. GoeddelNamed on SEC filing

Board

PSPeter Svennilson
Peter SvennilsoninBoard directorFounder / Managing Partner at The Column Group
ML
Mark LeschlyBoard director
DS
David SchnellBoard directorManaging Director at Prospect Venture Partners
MT
McHenry T. Tichenor, Jr.Board director

Investors · 3

Reported raises · per SEC filings

Form D private placements

$126.7M disclosed across 2 rounds · 2014–2015

$106MraisedMar 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark LeschlyDirector
  • Peter SvennilsonDirector
  • David SchnellDirector
  • David V. GoeddelDirector
  • Jin-Long ChenExecutive Officer, Director
  • William J. RieflinExecutive Officer, Director
  • McHenry T. Tichenor, Jr.Director
Offering amount
$106M
Amount sold
$106M
First sale
Mar 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$20.7MraisedFeb 2015 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • McHenry T. Tichenor, Jr.Director
  • William J. RieflinExecutive Officer, Director
  • Peter SvennilsonDirector
  • Jin-Long ChenExecutive Officer, Director
  • Mark LeschlyDirector
  • David V. GoeddelDirector
  • David SchnellDirector
Offering amount
$60M
Amount sold
$20.7M
First sale
Oct 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who founded Ngm Biopharmaceuticals?
Ngm Biopharmaceuticals was founded by Jin-Long Chen.
Who are Ngm Biopharmaceuticals's investors?
Ngm Biopharmaceuticals's investors include Foresite Capital, Prospect Venture Partners, The Column Group.
How much funding has Ngm Biopharmaceuticals raised?
Ngm Biopharmaceuticals has disclosed $126.7M raised across 2 rounds.
Where is Ngm Biopharmaceuticals headquartered?
Ngm Biopharmaceuticals is headquartered in South San Francisco, US.